rc 3095 has been researched along with gastrins in 13 studies
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (gastrins) | Trials (gastrins) | Recent Studies (post-2010) (gastrins) |
---|---|---|---|---|---|
108 | 2 | 26 | 12,748 | 659 | 786 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (84.62) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, RZ; Groot, K; Pinski, J; Radulovic, S; Schally, AV; Yano, T | 1 |
Cai, RZ; Pinski, J; Radulovic, S; Rekasi, Z; Schally, AV; Yano, T | 1 |
Banas, M; Cai, RZ; DembiĆski, A; Konturek, SJ; Schally, AV; Warzecha, Z | 1 |
Cai, RZ; Milovanovic, S; Radulovic, S; Schally, AV; Szepeshazi, K; Szoke, B | 1 |
Miller, G; Radulovic, S; Schally, AV | 1 |
Groot, K; Halmos, G; Pinski, J; Reile, H; Schally, AV | 1 |
Groot, K; Halmos, G; Miller, G; Milovanovic, S; Radulovic, S; Reile, H; Schally, AV; Szepeshazi, K; Yano, T | 1 |
Cai, RZ; Groot, K; Halmos, G; O'Byrne, K; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
Groot, K; Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
Halmos, G; Pinski, J; Schally, AV | 1 |
Groot, K; Halmos, G; Schally, AV; Szepeshazi, K | 1 |
Bajo, AM; Groot, K; Hebert, F; Krupa, M; Schally, AV; Szepeshazi, K | 1 |
Cancella, A; da Rocha, AB; De Nucci, G; DiLeone, LP; Horowitz, M; Pereira, AS; Pohlmann, P; Richter, M; Schunemann, D; Schwartsmann, G; Souza, F; Souza, FH | 1 |
1 trial(s) available for rc 3095 and gastrins
Article | Year |
---|---|
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bombesin; Female; Gastrin-Releasing Peptide; Gastrins; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pain; Peptide Fragments; Skin | 2006 |
12 other study(ies) available for rc 3095 and gastrins
Article | Year |
---|---|
Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Bombesin; Endocrine Glands; Gastrin-Releasing Peptide; Gastrins; Glucagon; Growth Hormone; Insulin; Male; Molecular Sequence Data; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley | 1992 |
High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration.
Topics: Administration, Inhalation; Animals; Bombesin; Gastrin-Releasing Peptide; Gastrins; Injections, Intravenous; Injections, Subcutaneous; Male; Peptide Fragments; Peptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 1992 |
The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Topics: Animals; Benzodiazepinones; Bombesin; Cholecystokinin; Devazepide; DNA; Duodenum; Eating; Fasting; Gastric Mucosa; Gastrins; Intestinal Mucosa; Male; Pancreas; Parietal Cells, Gastric; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Bombesin; Receptors, Cholecystokinin; Receptors, Neurotransmitter | 1991 |
Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Bombesin; Carcinogens; Cell Membrane; Cricetinae; ErbB Receptors; Female; Gastrins; Mesocricetus; Molecular Sequence Data; Nitrosamines; Organ Size; Pancreatic Neoplasms; Peptide Fragments; Receptors, Bombesin; Receptors, Neurotransmitter; Somatostatin | 1991 |
Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; Cell Line; Colonic Neoplasms; Gastrins; Growth Hormone; Humans; Insulin-Like Growth Factor I; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Somatostatin; Transplantation, Heterologous | 1991 |
Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bombesin; Castration; Cell Division; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrins; Growth Hormone; Male; Molecular Sequence Data; Neoplasm Transplantation; Peptide Fragments; Prostatic Neoplasms; Rats; Somatostatin | 1994 |
Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bombesin; Colonic Neoplasms; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Humans; Insulin-Like Growth Factor I; Liver Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Peptides; Radioligand Assay; Somatostatin | 1994 |
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Binding Sites; Body Weight; Bombesin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Gastrin-Releasing Peptide; Gastrins; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Peptide Fragments; Peptides; Receptors, Somatotropin; Somatostatin; Substrate Specificity; Transplantation, Heterologous | 1994 |
Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Topics: Amino Acid Sequence; Animals; Bombesin; Cell Division; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrins; Glioblastoma; Male; Mice; Mice, Nude; Molecular Sequence Data; Peptide Fragments; Receptors, Bombesin; Somatostatin; Tumor Cells, Cultured | 1994 |
Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.
Topics: Amino Acid Sequence; Androgens; Animals; Binding Sites; Body Weight; Bombesin; Cell Line; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Humans; Male; Mice; Mice, Nude; Molecular Sequence Data; Peptide Fragments; Peptides; Prostatic Neoplasms; Somatostatin | 1993 |
Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
Topics: Animals; Body Weight; Bombesin; Carcinoma; Cricetinae; Dose-Response Relationship, Drug; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Insulin-Like Growth Factor I; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Peptide Fragments; Peptides; Receptors, Bombesin; Receptors, Neurotransmitter | 1993 |
Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
Topics: Adult; Animals; Bombesin; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Epidermal Growth Factor; Estrogens; Female; Gastrins; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptor, ErbB-2; RNA, Messenger; Tumor Cells, Cultured | 2002 |